BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35196832)

  • 1. A comparison of the diagnostic performance of the O-RADS, RMI4, IOTA LR2, and IOTA SR systems by senior and junior doctors.
    Guo Y; Zhao B; Zhou S; Wen L; Liu J; Fu Y; Xu F; Liu M
    Ultrasonography; 2022 Jul; 41(3):511-518. PubMed ID: 35196832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic efficiency between IOTA LR2 model and doctors
    Zhao B; Fu Y; Wen L; Wang Z; Fu C; Liu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1082-1088. PubMed ID: 36097776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
    Yang Y; Ju H; Huang Y
    Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
    Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
    BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
    Poonyakanok V; Tanmahasamut P; Jaishuen A
    J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study.
    Filiz AA; Kahyaoglu S; Atalay CR
    Obstet Gynecol Sci; 2024 Jan; 67(1):86-93. PubMed ID: 37822234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
    Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses.
    Pelayo M; Pelayo-Delgado I; Sancho-Sauco J; Sanchez-Zurdo J; Abarca-Martinez L; Corraliza-Galán V; Martin-Gromaz C; Pablos-Antona MJ; Zurita-Calvo J; Alcázar JL
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving diagnostic strategies for ovarian cancer in Filipino women using ultrasound imaging and a multivariate index assay.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Cancer Epidemiol; 2022 Dec; 81():102253. PubMed ID: 36179631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast-enhanced ultrasound, IOTA simple rules and O-RADS for assessing the malignant risk of sonographically appearing solid ovarian masses.
    Lu B; Liu C; Qi J; He W; Shi T; Zhu Y; Huang B
    J Gynecol Obstet Hum Reprod; 2023 Apr; 52(4):102564. PubMed ID: 36868504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of differences in O-RADS lexicon interpretation between senior and junior sonologists on O-RADS classification and diagnostic performance.
    Yang Y; Wang H; Liu Z; Su N; Gao L; Tao X; Zhang R; Gu Y; Ma L; Wang R; Xu W; Xie Y; Zhang W; Zhang H; Xue G; Ru T; Dai Q; Li J; Jiang Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12275-12283. PubMed ID: 37430161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American college of radiology ovarian-adnexal reporting and data system ultrasound (O-RADS): Diagnostic performance and inter-reviewer agreement for ovarian masses in children.
    Wang H; Wang L; An S; Ma Q; Tu Y; Shang N; Pan Y
    Front Pediatr; 2023; 11():1091735. PubMed ID: 36969276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple rules, O-RADS, ADNEX and SRR model: Single oncologic center validation of diagnostic predictive models alone and combined (two-step strategy) to estimate the risk of malignancy in adnexal masses and ovarian tumors.
    Spagnol G; Marchetti M; De Tommasi O; Vitagliano A; Cavallin F; Tozzi R; Saccardi C; Noventa M
    Gynecol Oncol; 2023 Oct; 177():109-116. PubMed ID: 37660412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Simple Ultrasound Rules by International Ovarian Tumor Analysis (IOTA) with RMI-1 and RMI-4 (Risk of Malignancy Index) in Preoperative Differentiation of Benign and Malignant Adnexal Masses.
    Dewangan S; Gupta S; Chawla I
    J Obstet Gynaecol India; 2024 Apr; 74(2):158-164. PubMed ID: 38707882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of American College of Radiology Ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
    Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
    J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.